PT Millennium Pharmacon International Tbk (IDX:SDPC)
193.00
+1.00 (0.52%)
Apr 28, 2026, 3:33 PM WIB
IDX:SDPC Revenue
In the year 2025, PT Millennium Pharmacon International Tbk had annual revenue of 4.11T IDR with 4.93% growth. PT Millennium Pharmacon International Tbk had revenue of 1.11T in the quarter ending December 31, 2025, with 11.57% growth.
Revenue
4.11T
Revenue Growth
+4.93%
P/S Ratio
0.06
Revenue / Employee
3.43B
Employees
1,197
Market Cap
245.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.11T | 192.95B | 4.93% |
| Dec 31, 2024 | 3.92T | 553.35B | 16.45% |
| Dec 31, 2023 | 3.36T | 162.68B | 5.08% |
| Dec 31, 2022 | 3.20T | 211.98B | 7.09% |
| Dec 31, 2021 | 2.99T | 345.22B | 13.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.59T |
| PT Phapros Tbk | 961.30B |
| PT Ikapharmindo Putramas Tbk | 377.10B |
| PT Royal Prima Tbk | 338.91B |
| PT Indofarma Tbk | 206.24B |